SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-193535
Filing Date
2014-05-12
Accepted
2014-05-12 07:05:17
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d709207d10q.htm 10-Q 604119
2 EX-31.1 d709207dex311.htm EX-31.1 9126
3 EX-31.2 d709207dex312.htm EX-31.2 9142
4 EX-32.1 d709207dex321.htm EX-32.1 6002
5 EX-99.1 d709207dex991.htm EX-99.1 37720
12 GRAPHIC g709207g40q91.jpg GRAPHIC 4476
  Complete submission text file 0001193125-14-193535.txt   4441987

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akba-20140331.xml EX-101.INS 527157
7 XBRL TAXONOMY EXTENSION SCHEMA akba-20140331.xsd EX-101.SCH 45646
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20140331_cal.xml EX-101.CAL 66516
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20140331_def.xml EX-101.DEF 168835
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20140331_lab.xml EX-101.LAB 344090
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20140331_pre.xml EX-101.PRE 260343
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 14831168
SIC: 2834 Pharmaceutical Preparations